577 F.Supp.2d 1174 (D.N.M. 2008), Civ. 06-0874, Rimbert v. Eli Lilly and Co.
Linked as:
Extract
577 F.Supp.2d 1174 (D.N.M. 2008), Civ. 06-0874, Rimbert v. Eli Lilly and Co.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- US Code - 18 U.S.C. § 1001 Statements Or Entries Generally
- US Code - 21 U.S.C. § 331 Prohibited Acts
- US Code - 21 U.S.C. § 332 Injunction Proceedings
- US Code - 21 U.S.C. § 337 Proceedings In Name of United States; Provision As to Subpoenas
